Top rated prostate cancer clinical trials in Ventura, California
Here are the top 10 medical studies for prostate cancer in Ventura, California
Popular filter options for prostate-cancer ventura trials
Phase 3 Clinical Trials
View 100 phase 3 medical studies.
Cancer Vaccine
ProstAtak® Immunotherapy + Radiation for Prostate Cancer
Recruiting1 awardPhase 3
Tustin, California
This trial is testing whether adding ProstAtak immunotherapy to radiation therapy can improve outcomes for patients with localized prostate cancer at high or intermediate risk for the disease coming back.
PARP Inhibitor
Olaparib + Abiraterone for Prostate Cancer
Recruiting1 awardPhase 3
Los Angeles, California
This trial is testing the combination of olaparib and abiraterone versus placebo and abiraterone to see if it is more effective and has fewer side effects in patients with mCRPC who have not received prior chemotherapy or NHAs.
Clinical Trials With No Placebo
View 100 medical studies that do not have a placebo group.
Ultrasound Therapy
MRI-guided Transurethral Ultrasound Ablation for Prostate Cancer
Recruiting1 award14 criteria
Los Angeles, California
This trial is testing a new cancer treatment that uses MRI-guided ultrasound to destroy prostate tissue in 150 patients. The goal is to evaluate the safety and effectiveness of this new therapy.
Monoclonal Antibodies
sEphB4-HSA + Pembrolizumab for Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a new cancer treatment that uses a fusion protein and an anti-PD1 antibody. There will be four cohorts of patients with different types of cancer, all of whom have not responded well to other treatments.
XPO1 inhibitor
KPT-8602 for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
Pasadena, California
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Chemotherapy
PT-112 Injection for Advanced Prostate Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is testing a new cancer drug, PT-112. It is in two parts, the first of which has finished enrolling. The second part is testing PT-112's safety and how well it works in patients with thymoma or thymic carcinoma, and in patients with metastatic castrate-resistant prostate cancer.
View More Prostate-cancer Ventura Trials
See another 82 medical studies focused on prostate-cancer ventura.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.